Advanced Dysrhythmias Practice Exam

Non-sustained ventricular tachycardia (NSVT) is often managed with beta-blockers as they are effective in reducing the frequency of these arrhythmias. Beta-blockers work by blocking the action of adrenaline on the heart, which helps to decrease heart rate and myocardial oxygen demand, thus stabilizing the myocardium and preventing further episodes of tachycardia. In the case of NSVT, the arrhythmia may occur in the absence of significant heart disease but can also be associated with underlying conditions. Beta-blockers are especially useful because they can help control the heart rate and reduce the excitability of the cardiac tissue, which lowers the likelihood of re-entrant mechanisms that can lead to tachycardia. Other treatments, such as inhaled corticosteroids, anticoagulant therapy, and insulin administration, are not applicable for managing NSVT. Inhaled corticosteroids are primarily used for respiratory conditions, anticoagulants are prescribed to prevent blood clots, and insulin is used for managing diabetes. Therefore, the use of beta-blockers as a therapeutic approach in NSVT is well-supported by clinical practice guidelines and evidence.